BioSimilar Sciences

Biosimilar Sciences PR LLC is a global biotechnology company dedicated to developing and commercializing high-quality, affordable biosimilar therapeutics. Headquartered in Aguadilla, Puerto Rico, the company focuses on critical therapeutic areas such as oncology, immunology, and metabolic disorders. Its pipeline includes biosimilars for blockbuster biologics like Neupogen (filgrastim), Neulasta (pegfilgrastim), Aranesp (darbepoetin alfa), and Humira (adalimumab). Through strategic partnerships with OcyonBio and Ipca Laboratories, Biosimilar Sciences leverages advanced sterile manufacturing capabilities and regulatory expertise to expand patient access to life-saving biologic medicines across North America and global markets.